NUVOX PHARMA, L.L.C.

Tucson, AZ · Biotech · Private

NanO2 (dodecafluoropentane emulsion), an intravenous therapeutic to preserve brain tissue in acute ischemic stroke

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · nuvoxpharma.com

Sector: Biotech
Headquarters: Tucson, AZ
Total capital: $4.1M

Federal grants: $3.7M; 5 awards · 2017–2023; Rank in peer group#258 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $356K; 1 award · Health and Human S; Rank in Biotech#247 of 4373
Granted patents: 0; 2 pending

Capital timeline

Latest events

Jul 2023Federal contractHealth and Human S · Research And Development - Aoi #19 For The Development Of Novel Oxygen Therapeutic NAN02 For COVID19: Extend$356K
Apr 2023Federal grantHealth and Human S · Phase II · Dodecafluoropentane emulsion (DDFPe), NanO2™ as Cerebroprotectant in Ischemic Stroke$301K
Sep 2021Federal grantHealth and Human S · Phase I · NanO2 as a Cerebroprotectant in a tMCAO Stroke Model in Mice$478K
Dec 2017Federal grantHealth and Human S · Phase I · Development of a syringe/sonication device employed to administer DDFPe in the prehospital setting$144K
Sep 2017Federal grantHealth and Human S · Phase II · Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma$2.5M
Apr 2017Federal grantHealth and Human S · Phase I · Dodecafluoropentane Prevents Ischemia Reperfusion Injury in Contemporary Acute Myocardial Infarction Management$318K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 2

PendingBuffered Oxygen TherapeuticUSPTOApplication PCTUS2012060284
PendingMicrobubble Compositions, Method Of Making Same, And Method Using SameUSPTOApplication PCTUS2012047441

ENRICH BIOSYSTEMS INCSimilar federal contract value in Biotech · $400K in contracts
CYTOBIOSCIENCE INCSimilar federal contract value in Biotech · $387K in contracts
SIGNABLOK, INC.Similar federal contract value in Biotech · $370K in contracts
CLOVERLEAF BIO, INC.Similar federal contract value in Biotech · $355K in contracts
MATRISOME BIO, INC.Similar federal contract value in Biotech · $354K in contracts
Longevity Biotech, IncSimilar federal contract value in Biotech · $348K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.